2172 — Microport NeuroTech Balance Sheet
0.000.00%
HealthcareSpeculativeMid Cap
- HK$3.64bn
- HK$3.70bn
- CNY665.62m
Annual balance sheet for Microport NeuroTech, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 22.2 | 425 | 593 | 1,135 | 1,069 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 49.4 | 44.5 | 71.7 | 13.4 | 33.9 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 122 | 540 | 784 | 1,285 | 1,333 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 48.5 | 60.3 | 217 | 196 | 164 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 335 | 786 | 1,340 | 1,817 | 1,961 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 152 | 94.8 | 174 | 244 | 249 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 167 | 413 | 1,515 | 344 | 325 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 168 | 373 | -175 | 1,473 | 1,636 |
Total Liabilities & Shareholders' Equity | 335 | 786 | 1,340 | 1,817 | 1,961 |
Total Common Shares Outstanding |